Dianthus Therapeutics, Inc. (DNTH)

Dianthus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	314.17	132.33	15.37	7.64
Short-Term Investments	46.54	41.39	60.13	-
Cash & Short-Term Investments	360.71	173.72	75.49	7.64
Cash Growth	490.52%	130.12%	888.35%	-
Receivables	1.68	0.48	5.64	1.48
Inventory	2.31	2.16	0.82	0.24
Prepaid Expenses	1	1.1	0.09	0.02
Other Current Assets	-	-	-	0.01
Total Current Assets	365.69	177.45	82.03	9.39
Property, Plant & Equipment	0.63	0.8	0.96	0.03
Other Long-Term Assets	2.64	1.15	0.12	0.03
Total Assets	368.96	179.41	83.11	9.45
Accounts Payable	3.7	2.61	1.17	1.36
Accrued Expenses	5.86	6.5	6.61	3.99
Current Portion of Leases	0.38	0.42	0.35	-
Current Unearned Revenue	0.1	0.1	0.1	-
Total Current Liabilities	10.03	9.63	8.23	5.35
Long-Term Leases	0.03	0.17	0.44	-
Long-Term Unearned Revenue	0.68	0.74	0.79	-
Total Liabilities	10.74	10.54	9.45	5.35
Common Stock	0.03	0.02	-	-
Additional Paid-In Capital	479	258.23	1.66	0.14
Retained Earnings	-120.78	-89.42	-45.87	-17.39
Comprehensive Income & Other	-0.04	0.05	-0.16	-
Total Common Equity	358.22	168.87	-44.37	-17.25
Shareholders' Equity	358.22	168.87	73.66	4.1
Total Liabilities & Equity	368.96	179.41	83.11	9.45
Total Debt	0.41	0.59	0.79	-
Net Cash (Debt)	360.3	173.13	74.7	7.64
Net Cash Growth	496.24%	131.76%	878.03%	-
Net Cash Per Share	17.48	33.60	85.45	1.91
Filing Date Shares Outstanding	29.35	29.35	4.01	4.01
Total Common Shares Outstanding	29.35	14.82	4.01	4.01
Working Capital	355.66	167.82	73.81	4.04
Book Value Per Share	12.20	11.40	-11.05	-4.31
Tangible Book Value	358.22	168.87	-44.37	-17.25
Tangible Book Value Per Share	12.20	11.40	-11.05	-4.31
Machinery	0.33	0.28	0.17	-
Construction In Progress	-	-	-	0.03

Source: S&P Capital IQ. Standard template. Financial Sources.